Longevity Mythbusting

The longevity space is full of noise. Some of it comes from well-meaning but outdated research. Some of it comes from influencers whose primary expertise is in monetizing anxiety. And some of it is genuinely dangerous misinformation that leads people to avoid effective treatments or pursue ineffective ones.

Let’s address the five myths we encounter most often in clinical practice, and replace them with what the evidence actually shows.

This fear traces directly to a 2002 study from the Women’s Health Initiative that reported increased rates of breast cancer and cardiovascular disease in women taking a specific form of combined hormone therapy. The study made international headlines. The nuance did not.

What the headlines missed: the study used synthetic progestins rather than bioidentical progesterone, and oral rather than transdermal estrogen. These distinctions matter enormously. Subsequent research, including reanalysis of the original WHI data, has shown that the risks were substantially tied to these specific formulations, and that the benefits of appropriately administered hormone therapy, including reduced osteoporosis, improved cardiovascular outcomes, lower dementia risk, and significantly better quality of life, are well-supported.

The risk profile of hormone therapy depends on the hormone type, the delivery method, the dose, the timing of initiation relative to menopause, and the individual’s health history. Assuming all hormone therapy is dangerous because of one study using one formulation is like concluding that all antibiotics are harmful because one type caused a reaction in one member.

The idea that metabolism is a fixed biological fate, something you are simply stuck with, is both common and incorrect. Metabolic rate does slow modestly with age. But the primary driver of that slowdown is not age itself; it is the loss of muscle mass that typically accompanies aging in people who are not actively working against it.

Skeletal muscle is metabolically expensive tissue. It burns calories at rest, improves insulin sensitivity, and regulates glucose metabolism. When you lose muscle, your resting metabolic rate declines. This is not a mysterious hormonal phenomenon. It is a straightforward mechanical one.

The practical implication: strength training reverses this. People who maintain consistent resistance training into their 70s and 80s preserve metabolic function that sedentary peers have lost. The dimmer switch can be turned back up. It requires effort, but it is not complicated.

Body Mass Index was designed as a population-level statistical tool in the 19th century. It has no ability to distinguish between muscle and fat, does not account for age or sex differences in body composition, and consistently misclassifies both athletes (as overweight) and metabolically sick individuals (as healthy).

The TOFI phenomenon illustrates this perfectly. TOFI stands for Thin Outside, Fat Inside. These are individuals with a normal or low BMI who carry significant visceral fat, the metabolically active fat that surrounds internal organs and drives insulin resistance, inflammation, and cardiovascular risk. Their BMI suggests health. Their metabolic profile tells a different story.

Body composition testing via DEXA scan or bioelectrical impedance analysis measures what actually matters: lean body mass versus fat mass, and particularly the distribution of visceral versus subcutaneous fat. These are the numbers that correlate with metabolic health outcomes. BMI does not.

There is a version of longevity medicine that is essentially supplement marketing with a clinical veneer. The implicit promise is that if you take the right combination of capsules, you can offset a poor diet, inadequate sleep, and a sedentary lifestyle. This is false, and it is worth being direct about that.

Supplements have a legitimate and evidence-based role in precision medicine. Omega-3 fatty acids, Vitamin D, targeted B vitamins, and a small number of other compounds have meaningful effects on specific measurable biomarkers. But they operate at the margins of a system that must first be built on a functional foundation.

A high-quality fish oil supplement will not counteract 10 years of metabolic dysfunction. A Vitamin D capsule will not replace the cardiovascular benefits of regular exercise. These tools are fine-tuning instruments for a well-maintained engine, not repair kits for a broken one.

Weight loss is often a byproduct of health improvements. It is rarely the most important one, and treating it as the primary goal frequently leads people in the wrong direction.

The scale does not tell you whether you lost fat or muscle. It does not tell you whether your visceral fat burden increased or decreased. It does not reflect your insulin sensitivity, your inflammatory load, your cardiovascular risk, or your functional strength. It tells you your gravitational relationship with the earth, and not much else that is clinically relevant.

We see members who have lost significant weight and whose metabolic markers have worsened because the weight loss came at the expense of muscle mass. We also see members who are heavier than their doctors have suggested they should be, but whose body composition, metabolic function, and cardiovascular profile are excellent.

The goal is health, not thinness. Body composition, metabolic markers, and functional fitness are the measures that matter.